Healthcare -
Biotechnology - NASDAQ - US
$ 22.04
-0.136 %
$ 3.74 B
Market Cap
-9.97
P/E
IMVT - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss IMVT - Immunovant, Inc.
1.91 M
LAST VALUE
117.32%
2 YEAR CAGR
40.95%
5 YEAR CAGR
0.00%
10 YEAR CAGR